Research

Sales data from March indicate that a trend change in housing prices might be underway in the beleaguered Phoenix metro market.

From seasoned real estate writer Steve Bergsman comes this message: Proceed with caution, be patient and realize that there are many kinds of real estate markets — each with particular potentials and pitfalls.

Roger Myerson, a Nobel Laureate in Economics from the University of Chicago, told an audience of Chinese business executives and government officials recently that their country might do better if it liquidated some of its American investments.

Back in the early 1990s, the Phoenix metro area — like the rest of the country — was suffering through a profound real estate recession and house prices declined for a record 17 straight months. Like Lou Gehrig's record for consecutive games played, it was thought it would never be equaled.

Infrastructure is the foundation of an economy: schools, transportation, power plants, etc. Arizona faces challenges meeting current infrastructure needs and preparing for growth.

"A leading company should be a company of leaders," says Dov Seidman, a consultant whose career focuses on how companies and their people can operate in both a principled and profitable way.

In the late 1980s home prices in Phoenix declined for a grueling 17 straight months before bottoming out in the early 1990s. That downturn pummeled the savings and loan industry, and it set the record for length.

It's official: The U.S. economy is in recession — and has been since December 2007, according to the National Bureau of Economic Research.

In the opening moments of Bob Anderson's presentation at a recent conference sponsored by the Center for the Advancement of Business through Information Technology, the IT executive used the words "innovation" or "innovative" or "innovate" seven times. He has reasons to harp on that theme.

The future of the pharmaceutical industry lies in its willingness to share scientific information, tailor drugs for individual patient groups and have the courage to walk away from some therapies in order to improve outcomes in other areas, says Eli Lilly and Company chairman of the board Sidney